Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 14, 2022
Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer Entities
Wolfgang P Fendler, Kim M Pabst, Lukas Kessler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 19, 2026
<sup>90</sup>Y-FAPI-46 Radiopharmaceutical Therapy in Sarcoma and Other Solid Tumors: An Updated Cohort Analysis
Helena Lanzafame, Ilektra A Mavroeidi, Kim M Pabst, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 8, 2026
Prognostic Value of Fibroblast Activation Protein-Directed PET Imaging in Pleural Mesothelioma
Lukas Kessler, Felix Schwaning, Martin Metzenmacher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 23, 2024
Prognostic Implications of <sup>68</sup>Ga-FAPI-46 PET/CT-Derived Parameters on Overall Survival in Various Types of Solid Tumors
Masao Watanabe, Wolfgang P Fendler, Hong Grafe, et al.
Annals of Nuclear Medicine
|
October 23, 2024
Head-to-head comparison of <sup>68</sup> Ga-FAPI-46 PET/CT, <sup>18</sup>F-FDG PET/CT, and contrast-enhanced CT for the detection of various tumors
Masao Watanabe, Wolfgang P Fendler, Hong Grafe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 6, 2023
Superior Tumor Detection for <sup>68</sup>Ga-FAPI-46 Versus <sup>18</sup>F-FDG PET/CT and Conventional CT in Patients with Cholangiocarcinoma
Kim M Pabst, Marija Trajkovic-Arsic, Phyllis F Y Cheung, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 25, 2025
Potential value of [<sup>68</sup>Ga]Ga-FAPI-46 PET in patients with metastatic urothelial carcinoma: a bi-centric analysis
Kim M Pabst, Sophie C Siegmund, Adrien Holzgreve, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 3, 2024
The Role of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma: A Comparison of Tissue, <sup>68</sup>Ga-FAPI-46 PET Data, and Survival Data
Christoph Oster, Lukas Kessler, Tobias Blau, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 25, 2023
<sup>68</sup>Ga-FAPI PET/CT Interobserver Agreement on Tumor Assessment: An International Multicenter Prospective Study
Riccardo Mei, Lukas Kessler, Kim M Pabst, et al.
Neuro-Oncology Advances
|
January 7, 2026
Distribution and prognostic significance of myelotoxicity in newly diagnosed glioblastoma in a real-life cohort: Time to treat more aggressively?
Christoph Oster, Pia Reineck, Teresa Schmidt, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 14, 2022
Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer Entities
Wolfgang P Fendler, Kim M Pabst, Lukas Kessler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 19, 2026
<sup>90</sup>Y-FAPI-46 Radiopharmaceutical Therapy in Sarcoma and Other Solid Tumors: An Updated Cohort Analysis
Helena Lanzafame, Ilektra A Mavroeidi, Kim M Pabst, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 8, 2026
Prognostic Value of Fibroblast Activation Protein-Directed PET Imaging in Pleural Mesothelioma
Lukas Kessler, Felix Schwaning, Martin Metzenmacher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 23, 2024
Prognostic Implications of <sup>68</sup>Ga-FAPI-46 PET/CT-Derived Parameters on Overall Survival in Various Types of Solid Tumors
Masao Watanabe, Wolfgang P Fendler, Hong Grafe, et al.
Annals of Nuclear Medicine
|
October 23, 2024
Head-to-head comparison of <sup>68</sup> Ga-FAPI-46 PET/CT, <sup>18</sup>F-FDG PET/CT, and contrast-enhanced CT for the detection of various tumors
Masao Watanabe, Wolfgang P Fendler, Hong Grafe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 6, 2023
Superior Tumor Detection for <sup>68</sup>Ga-FAPI-46 Versus <sup>18</sup>F-FDG PET/CT and Conventional CT in Patients with Cholangiocarcinoma
Kim M Pabst, Marija Trajkovic-Arsic, Phyllis F Y Cheung, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 25, 2025
Potential value of [<sup>68</sup>Ga]Ga-FAPI-46 PET in patients with metastatic urothelial carcinoma: a bi-centric analysis
Kim M Pabst, Sophie C Siegmund, Adrien Holzgreve, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 3, 2024
The Role of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma: A Comparison of Tissue, <sup>68</sup>Ga-FAPI-46 PET Data, and Survival Data
Christoph Oster, Lukas Kessler, Tobias Blau, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 25, 2023
<sup>68</sup>Ga-FAPI PET/CT Interobserver Agreement on Tumor Assessment: An International Multicenter Prospective Study
Riccardo Mei, Lukas Kessler, Kim M Pabst, et al.
Neuro-Oncology Advances
|
January 7, 2026
Distribution and prognostic significance of myelotoxicity in newly diagnosed glioblastoma in a real-life cohort: Time to treat more aggressively?
Christoph Oster, Pia Reineck, Teresa Schmidt, et al.
Page
of 4